Atlas Trials

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Clinical trial NCT03300544 · TERMINATED

Trial details

NCT number
NCT03300544
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectal AdenocarcinomaStage III Rectal Cancer AJCC v7Stage IIIA Rectal Cancer AJCC v7Stage IIIB Rectal Cancer AJCC v7Stage IIIC Rectal Cancer AJCC v7Stage IV Rectal Cancer AJCC v7Stage IVA Rectal Cancer AJCC v7Stage IVB Rectal Cancer AJCC v7
Start date
2019-05-14
Primary completion
2022-03-22
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.